Logo image of STIM

NEURONETICS INC (STIM) Stock Overview

NASDAQ:STIM - US64131A1051 - Common Stock

3.31 USD
-0.07 (-2.07%)
Last: 8/27/2025, 1:28:05 PM

STIM Key Statistics, Chart & Performance

Key Statistics
52 Week High5.92
52 Week Low0.52
Market Cap218.86M
Shares66.12M
Float39.15M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.13
PEN/A
Fwd PEN/A
Earnings (Next)11-10 2025-11-10/bmo
IPO06-28 2018-06-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


STIM short term performance overview.The bars show the price performance of STIM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10 -15 -20

STIM long term performance overview.The bars show the price performance of STIM in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 50 100 150 200 250

The current stock price of STIM is 3.31 USD. In the past month the price decreased by -24.38%. In the past year, price increased by 282.74%.

NEURONETICS INC / STIM Daily stock chart

STIM Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 26.77 228.34B
ISRG INTUITIVE SURGICAL INC 58.94 170.09B
BSX BOSTON SCIENTIFIC CORP 37.57 157.53B
SYK STRYKER CORP 30.49 149.81B
MDT MEDTRONIC PLC 16.64 117.91B
BDX BECTON DICKINSON AND CO 13.67 55.89B
IDXX IDEXX LABORATORIES INC 53.25 51.17B
EW EDWARDS LIFESCIENCES CORP 31.63 47.73B
RMD RESMED INC 29.57 41.34B
GEHC GE HEALTHCARE TECHNOLOGY 15.88 33.79B
DXCM DEXCOM INC 45.04 30.02B
PHG KONINKLIJKE PHILIPS NVR- NY 16.47 26.64B

About STIM

Company Profile

STIM logo image Neuronetics, Inc. is a commercial stage medical technology company, which focuses on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders. The company is headquartered in Malvern, Pennsylvania and currently employs 716 full-time employees. The company went IPO on 2018-06-28. The Company’s NeuroStar Advanced Therapy (NeuroStar Therapy) is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. In addition to selling the NeuroStar Advanced Therapy System (NeuroStar System) and associated treatment sessions to customers, it operates Greenbrook treatment centers across the United States, offering NeuroStar Therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. MDD is a recurrent disease and follows a fluctuating course over an individual’s lifetime. The firm provides more than 7.1 million treatments to over 1,95,000 patients.

Company Info

NEURONETICS INC

3222 Phoenixville Pike

Malvern PENNSYLVANIA 19355 US

CEO: Keith J. Sullivan

Employees: 716

STIM Company Website

STIM Investor Relations

Phone: 18776007555

NEURONETICS INC / STIM FAQ

What is the stock price of NEURONETICS INC today?

The current stock price of STIM is 3.31 USD. The price decreased by -2.07% in the last trading session.


What is the ticker symbol for NEURONETICS INC stock?

The exchange symbol of NEURONETICS INC is STIM and it is listed on the Nasdaq exchange.


On which exchange is STIM stock listed?

STIM stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for NEURONETICS INC stock?

9 analysts have analysed STIM and the average price target is 6.63 USD. This implies a price increase of 100.3% is expected in the next year compared to the current price of 3.31. Check the NEURONETICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NEURONETICS INC worth?

NEURONETICS INC (STIM) has a market capitalization of 218.86M USD. This makes STIM a Micro Cap stock.


How many employees does NEURONETICS INC have?

NEURONETICS INC (STIM) currently has 716 employees.


What are the support and resistance levels for NEURONETICS INC (STIM) stock?

NEURONETICS INC (STIM) has a support level at 3.33 and a resistance level at 3.41. Check the full technical report for a detailed analysis of STIM support and resistance levels.


Is NEURONETICS INC (STIM) expected to grow?

The Revenue of NEURONETICS INC (STIM) is expected to grow by 109.15% in the next year. Check the estimates tab for more information on the STIM EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NEURONETICS INC (STIM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NEURONETICS INC (STIM) stock pay dividends?

STIM does not pay a dividend.


When does NEURONETICS INC (STIM) report earnings?

NEURONETICS INC (STIM) will report earnings on 2025-11-10, before the market open.


What is the Price/Earnings (PE) ratio of NEURONETICS INC (STIM)?

NEURONETICS INC (STIM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.13).


What is the Short Interest ratio of NEURONETICS INC (STIM) stock?

The outstanding short interest for NEURONETICS INC (STIM) is 13.44% of its float. Check the ownership tab for more information on the STIM short interest.


STIM Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to STIM. When comparing the yearly performance of all stocks, STIM is one of the better performing stocks in the market, outperforming 97.78% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

STIM Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to STIM. STIM may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

STIM Financial Highlights

Over the last trailing twelve months STIM reported a non-GAAP Earnings per Share(EPS) of -1.13. The EPS decreased by -0.89% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -36.24%
ROE -179.75%
Debt/Equity 2.05
Chartmill High Growth Momentum
EPS Q2Q%54.55%
Sales Q2Q%131.66%
EPS 1Y (TTM)-0.89%
Revenue 1Y (TTM)54.18%

STIM Forecast & Estimates

9 analysts have analysed STIM and the average price target is 6.63 USD. This implies a price increase of 100.3% is expected in the next year compared to the current price of 3.31.

For the next year, analysts expect an EPS growth of 57.31% and a revenue growth 109.15% for STIM


Analysts
Analysts82.22
Price Target6.63 (100.3%)
EPS Next Y57.31%
Revenue Next Year109.15%

STIM Ownership

Ownership
Inst Owners25.75%
Ins Owners6.41%
Short Float %13.44%
Short Ratio4.38